Efficacy and safety of high-dose chemotherapy as second or subsequent salvage therapy in relapsed or refractory germ cell cancer patients: A multicentric analysis

被引：0

作者：

Seidel, C. ^{[1
]}

De Giorgi, U. F. F. ^{[2
]}

Engel, N. ^{[1
]}

Hentrich, M. ^{[3
]}

Zschaebitz, S. ^{[4
]}

Conolly, E. ^{[5
]}

Weickhardt, A. J. ^{[6
]}

Grimison, P. ^{[7
]}

Wong, V. ^{[8
]}

Oing, C. ^{[9
]}

Alsdorf, W. ^{[1
]}

Schaefers, C. ^{[1
]}

Bokemeyer, C. ^{[1
]}

Tran, B. ^{[10
]}

机构：

[1] UKE Univ Klinikum Hamburg Eppendorf KMTZ, Oncol Hematol & Bone Marrow Transplantat, Hamburg, Germany

[2] IRST Ist Romagnolo Studio Tumori Dino Amadori IRC, Med Oncol Dept, Meldola, Italy

[3] Rotkreuzklinikum Munchen, Dept Hematol & Oncol, Munich, Germany

[4] NCT Nationales Zentrum Tumorerkrankungen, Med Oncol Dept, Heidelberg, Germany

[5] Chris OBrien Lifehouse, Oncol, Sydney, NSW, Australia

[6] Olivia Newton John Canc Wellness & Res Ctr, Med Oncol Dept, Heidelberg, Vic, Australia

[7] Chris OBrien Lifehouse, Dept Med Oncol, Camperdown, NSW, Australia

[8] WEHI Walter & Eliza Hall Inst Med Res, Oncol, Parkville, Vic, Australia

[9] Newcastle Univ, Sir Bobby Robson Clin Trials Res Ctr, Newcastle Upon Tyne, England

[10] Peter MacCallum Canc Ctr, Med Oncol Dept, Melbourne, Vic, Australia

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.09.678

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

732P

引用

页码：S503 / S503

页数：1

共 50 条

[1] Efficacy and safety of high-dose chemotherapy as the first or subsequent salvage treatment line in patients with relapsed or refractory germ cell cancer: an international multicentric analysis
Schaefers, C.
Connolly, E. A.
Weickhardt, A.
Grimison, P.
Wong, V.
De Giorgi, U.
Hentrich, M.
Zschaebitz, S.
Ochsenreither, S.
Vincenzi, B.
Oing, C.
Bokemeyer, C.
Engel, N.
Alsdorf, W.
Tran, B.
ESMO OPEN, 2024, 9 (05)
[2] High-dose chemotherapy (HDCT) as second salvage treatment in patients with multiple relapsed or refractory germ cell tumors
Beyer, J.
Hackenthal, M.
Lorch, A.
Neubauer, A.
Dieing, A.
Rick, O.
Hartmann, J. T.
Bokemeyer, C.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[3] High-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumors
Lorch, A.
Neubauer, A.
Hackenthal, M.
Dieing, A.
Hartmann, J. T.
Rick, O.
Bokemeyer, C.
Beyer, J.
ANNALS OF ONCOLOGY, 2010, 21 (04) : 820 - 825
[4] Efficacy and safety of sequential high-dose chemotherapy (HDCT) for relapsed or refractory germ cell cancer in a unicentric standardized approach
Niegisch, G.
Henn, A.
Zaum, M.
Kobbe, G.
Haas, R.
Schirren, J.
Albers, P.
Lorch, A.
Oncology Research and Treatment, 2015, 38 : 86 - 86
[5] Comparison of efficacy and safety of high-dose chemotherapy as 1st salvage vs. 2nd or subsequent salvage therapy in relapsed or refractory germ cell tumor patients - a retrospective single-center analysis
Engel, N. W.
Oing, C.
Bokemeyer, C.
Seidel, C.
ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 73 - 73
[6] Is high-dose chemotherapy effective in patients with relapsed or refractory germ cell tumors?
Feldman, Darren R.
Motzer, Robert J.
Bajorin, Dean F.
NATURE CLINICAL PRACTICE UROLOGY, 2008, 5 (02): : 78 - 79
[7] Is high-dose chemotherapy effective in patients with relapsed or refractory germ cell tumors?
Darren R Feldman
Robert J Motzer
Dean F Bajorin
Nature Clinical Practice Urology, 2008, 5 : 78 - 79
[8] Salvage high-dose chemotherapy in female patients with relapsed/refractory germ cell tumors: The EBMT experience.
De Giorgi, Ugo
Richard, Sandrine
Badoglio, Manuela
Kanfer, Edward
Bourrhis, Jean Henri
Nicolas-Virelizier, Emmanuelle
Liouret, Bruno
Vettenranta, Kim
Martin, Sonja
Dreger, Peter
Schuler, Markus Kajo
Scarpi, Emanuela
Rosti, Giovanni
Selle, Frederic
Lanza, Francesco
Bregni, Marco
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[9] Residual tumor resection after high-dose chemotherapy in patients with relapsed or refractory germ cell cancer
Rick, O
Bokemeyer, C
Weinknecht, S
Schirren, J
Pottek, T
Hartmann, IT
Braun, T
Rachud, B
Weissbach, L
Hartmann, M
Siegert, W
Beyer, J
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (18) : 3713 - 3719
[10] The Role of Salvage High-Dose Chemotherapy in Relapsed Male Germ Cell Tumors
Oing, Christoph
Lorch, Anja
ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 (06) : 365 - 369

← 1 2 3 4 5 →